# Efficacy of a Dietary Supplement (Aqualief®) in Xerostomic Patients

> **NCT03612414** · NA · COMPLETED · sponsor: **Università degli Studi dell'Insubria** · enrollment: 60 (actual)

## Conditions studied

- Xerostomia Due to Hyposecretion of Salivary Gland
- pH
- Saliva
- Quality of Life

## Interventions

- **DIETARY_SUPPLEMENT:** Aqualief
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03612414
- **Lead sponsor:** Università degli Studi dell'Insubria
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-15
- **Primary completion:** 2017-10-31
- **Final completion:** 2017-12-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03612414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03612414, "Efficacy of a Dietary Supplement (Aqualief®) in Xerostomic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03612414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*